pubmed-article:11834956 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0023884 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0279030 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:11834956 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:11834956 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11834956 | pubmed:dateCreated | 2002-2-8 | lld:pubmed |
pubmed-article:11834956 | pubmed:abstractText | Although discrepancies between histological and virological responses to anti-hepatitis C virus (HCV) therapy are well-established in HIV-negative patients, the liver histological outcome has never been assessed in HIV-HCV co-infected patients receiving anti-HCV therapy. We compared histological responses to interferon (IFN) alpha therapy between HIV-positive and HIV-negative injecting drug users (IDU) and determined factors associated with histological response. | lld:pubmed |
pubmed-article:11834956 | pubmed:language | eng | lld:pubmed |
pubmed-article:11834956 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11834956 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11834956 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11834956 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11834956 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11834956 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11834956 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11834956 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11834956 | pubmed:issn | 0269-9370 | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:VallaDominiqu... | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:DegottClaudeC | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:Di... | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:ThevenotThier... | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:BoyerNathalie... | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:Cazals-HatemD... | lld:pubmed |
pubmed-article:11834956 | pubmed:author | pubmed-author:MarcellinPatr... | lld:pubmed |
pubmed-article:11834956 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11834956 | pubmed:day | 15 | lld:pubmed |
pubmed-article:11834956 | pubmed:volume | 16 | lld:pubmed |
pubmed-article:11834956 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11834956 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11834956 | pubmed:pagination | 441-5 | lld:pubmed |
pubmed-article:11834956 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:meshHeading | pubmed-meshheading:11834956... | lld:pubmed |
pubmed-article:11834956 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:11834956 | pubmed:articleTitle | HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C. | lld:pubmed |
pubmed-article:11834956 | pubmed:affiliation | Service d'Hépatologie, INSERM U481 et Centre de Recherche Claude Bernard sur les hépatites virales, 100 Bd du Général Leclerc, Hôpital Beaujon, 92110 Clichy, France. | lld:pubmed |
pubmed-article:11834956 | pubmed:publicationType | Journal Article | lld:pubmed |